Old Web
English
Sign In
Acemap
>
authorDetail
>
James P. Chovan
James P. Chovan
Novartis
Chemistry
Agonist
Adenosine
Endocrinology
Internal medicine
5
Papers
77
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Inhibition of LTB4 biosynthesis in situ by CGS 23885, a potent 5-lipoxygenase inhibitor, correlates with its pleural fluid concentrations in an experimentally induced rat pleurisy model
1997
Naunyn-schmiedebergs Archives of Pharmacology
A. Raychaudhuri
Herbert Chertock
James P. Chovan
Lisa S. Jones
Earl F. Kimble
Timothy J. Kowalski
Jane V. Peppard
D.Hope White
Yoshitaka Satoh
Dennis M. Roland
Show All
Source
Cite
Save
Citations (7)
Development of tolerance to the antihypertensive effects of highly selective adenosine A2a agonists upon chronic administration.
1993
Journal of Pharmacology and Experimental Therapeutics
Randy Lee Webb
Matthew A. Sills
James P. Chovan
Jane V. Peppard
John E. Francis
Show All
Source
Cite
Save
Citations (33)
CGS 21680 : a potent selective adenosine A2 receptor agonist
1992
Cardiovascular Drug Reviews
Randy Lee Webb
Matthew A. Sills
James P. Chovan
Joseph L. Balwierczak
John E. Francis
Show All
Source
Cite
Save
Citations (20)
Automated-extraction, high-performance liquid chromatographic method and pharmacokinetics in rats of a highly A2-selective adenosine agonist, CGS 21680
1992
Journal of Chromatography B: Biomedical Sciences and Applications
James P. Chovan
Patricia A. Zane
Gerald E. Greenberg
Show All
Source
Cite
Save
Citations (13)
High-performance liquid chromatographic method for a clozapine analogue, CGS 13429, and its N-oxide and desmethyl metabolites
1989
Journal of Chromatography B: Biomedical Sciences and Applications
James P. Chovan
Jeannette Dehaas Vermeulen
Show All
Source
Cite
Save
Citations (4)
1